Some Medicare recipients could save money on 34 prescription drugs - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Health/Employee Benefits News
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Health/Employee Benefits News
Health/Employee Benefits News RSS Get our newsletter
Order Prints
September 15, 2023 Health/Employee Benefits News
Share
Share
Post
Email

Some Medicare recipients could save money on 34 prescription drugs

Image of person in a medical smock holding a prescription bottle and writing something on a pad of paper.
By Wire Reports

The Centers for Medicare & Medicaid Services announced the list of 34 prescription drugs that may have a lower cost for Part B beneficiaries between Oct. 1 and Dec. 31.

Some people with Medicare who take these drugs may save between $1 and $618 per average dose starting Oct.1, 2023, depending on their individual coverage, CMS said this week.

The price reduction is part of the Inflation Reduction Act passed in August 2022.

Prescription drug provisions in the Inflation Reduction Act include:

  • For the first time, the federal government is required to negotiate prices for some of the highest-spending drugs covered under Medicare.
  • Requires drug companies to pay rebates if prices rise faster than inflation for drugs used by Medicare beneficiaries.
  • Eliminates the 5% coinsurance for catastrophic coverage in Medicare Part D in 2024, adds a $2,000 cap on Part D out-of-pocket spending in 2025 and limits annual increases in Part D premiums for 2024-2030.
  • Limits monthly cost sharing for insulin products to $35 for people with Medicare.
  • Expands eligibility for Medicare Part D low-income subsidy full benefits.
  • Eliminates cost sharing for adult vaccines covered under Medicare Part D and improves access to adult vaccines under Medicaid and the Children’s Health Insurance Program.

By reducing coinsurance for some people with Part B coverage and discouraging drug companies from increasing prices faster than inflation, CMS’ action may lower out-of-pocket costs for some people with Medicare and reduce Medicare program spending for costly drugs, the agency said.

Under the Inflation Reduction Act, people with Medicare may pay a lower coinsurance for some Part B drugs if the drug’s price increases faster than the rate of inflation. The lower Part B coinsurance on the listed drugs announced today will be in effect from Oct. 1 to Dec. 31. The coinsurance adjustment applies to certain drugs and biologicals paid under Medicare Part B. The Part B drugs impacted by this coinsurance adjustment may change quarterly.

The list of drugs impacted by the coinsurance adjustment includes:

  • Adcetris
  • Aggrastat
  • Akynzeo
  • Atgam
  • Bicillin CR
  • Bicillin L-A
  • Blincyto
  • Chirhostim
  • Cresemba
  • Crysvita
  • Fragmin
  • Humira
  • Hypertet
  • Imlygic
  • Infugem
  • Leukine
  • Lupron Depot-PED
  • Minocin
  • Nipent
  • Nplate
  • Oncaspar
  • Padcev
  • Panhematin
  • Pemetrexed
  • Romidepsin
  • Rybrevant
  • Signifor LAR
  • Sotalol
  • Sylvant
  • Synribo
  • Vabomere
  • Vectibix
  • Xiaflex
  • Zemdri

In August, CMS announced the first 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act.

Under the act, Medicare will be able to directly negotiate with drugmakers over prices for the costliest medications. The negotiated prices will go into effect in 2026.

 

Wire Reports

Older

Japan’s changing insurance industry can learn some lessons from the U.S. market

Newer

NC regulators release $1.2B from former Lindberg insurers in receivership

Advisor News

  • The Gen Z money paradox
  • NAIFA applauds final SECURE 2.0 regulations
  • What will Democrats in Congress do about healthcare and retirement?
  • Election results cloud retirement legislation outlook, experts say
  • Planning for the missing chapter
More Advisor News

Annuity News

  • NAIC task force to address LTC riders
  • ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
  • Jackson Launches Direct-to-Consumer Annuity Offering
  • Global Atlantic launches ForeIncome Flex
  • Athene CEO criticizes offshore reinsurance, risk-taking by competitors
More Annuity News

Life Insurance News

  • NAIC task force to address LTC riders
  • Protective names Kurt Meyers Chief Legal Officer and Fernando Levy Chief Digital & AI Officer
  • Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
  • Military Briefs: November 19-25
  • California’s new solvency rules: What should life insurance advisors watch?
More Life Insurance News

Property and Casualty News

  • TransUnion finds nearly 50% drop in renters becoming homeowners
  • Sterling Seacrest Pritchard named in Business Insurance’s Annual Best Places to Work in Insurance
  • NM’s ‘insurer of last resort’ to make all enrollees reapply
  • Texas P/C Insurance Affordability Tied to Complex Mix of Cost Drivers, Triple-I Issues Brief Finds
  • Lawton lawsuit against State Farm Insurance scheduled for trial Feb. 1, 2027
More Property and Casualty News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • OpenRoad Insurance Data Shows 40% of Collector Vehicles Are Model Year 1980 or Newer
  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.